Equivalence of Glatiramer Acetate Generics With Branded Glatiramer Acetate in Efficacy and Cost for the Treatment of Multiple Sclerosis
- PMID: 26457848
- DOI: 10.1001/jamaneurol.2015.2605
Equivalence of Glatiramer Acetate Generics With Branded Glatiramer Acetate in Efficacy and Cost for the Treatment of Multiple Sclerosis
Erratum in
- 
  
  Error in Text.JAMA Neurol. 2015 Dec;72(12):1537. doi: 10.1001/jamaneurol.2015.4174. JAMA Neurol. 2015. PMID: 26658977 No abstract available.
Comment in
- 
  
  Are the high-costs of MS disease-modifying therapies justified?Mult Scler Relat Disord. 2018 Feb;20:A3-A5. doi: 10.1016/j.msard.2018.02.018. Mult Scler Relat Disord. 2018. PMID: 29579631 No abstract available.
Comment on
- 
  
  Equivalence of Generic Glatiramer Acetate in Multiple Sclerosis: A Randomized Clinical Trial.JAMA Neurol. 2015 Dec;72(12):1433-41. doi: 10.1001/jamaneurol.2015.2154. JAMA Neurol. 2015. PMID: 26458034 Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
- Full Text Sources
- Medical
 
        